Recent data in transgenic mouse models indicated that Zeb2 knock-out is not sufficient to promote melanoma initiation in the mouse and even impairs NRASQ61-dependent melanoma formation [44], thus precluding a bona fide tumor-suppressor role. This evidence concerns the gene ZEB2 and melanoma.